Hikaru Sasaki

9PUBLICATIONS
0CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 02, 2024
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.

Hikaru Sasaki, Yohei Kitamura, Masahiro Toda

|Mar 09, 2023
Clinical, histopathological and molecular risk factors for recurrence of pilocytic astrocytomas: brainstem/spinal location, nestin expression and gain of 7q and 19 are associated with early tumor recurrence.

Ryota Tamura, Akio Iwanami, Kentaro Ohara

|Mar 16, 2022
The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas.

Eriel Sandika Pareira, Makoto Shibuya, Kentaro Ohara

|Oct 31, 2021
Histopathological investigation of the 1p/19q-codeleted gliomas resected following alkylating agent chemotherapy.

Tokunori Kanazawa, Kentaro Ohara, Yohei Kitamura

|Nov 28, 2019
Tumor immune microenvironment is associated with the growth of intracranial germinomas.

Masaaki Nishimoto, Kentaro Ohara, Dai Kamamoto

|Aug 13, 2019
Magnetic resonance imaging texture analyses in lower-grade gliomas with a commercially available software: correlation of apparent diffusion coefficient and T2 skewness with 1p/19q codeletion.

Tokunori Kanazawa, Yasuhiro Minami, Hidenori Takahashi

Pageof 2

Frequent Collaborators